cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal control in vitro and in vivo.

Abstract:

:An important feature of cytochrome P450 (CYP) 2B1 is its high ability to convert the prodrug cyclophosphamide (CPA) to therapeutically cytotoxic metabolites, resulting in interstrand DNA-cross-linking and cell death. We have examined whether and how the phosphorylation of CYP2B1 influences CPA metabolic activation in vitro and in vivo. We found first that only part of the total CYP2B1 pool undergoes phosphorylation. This part is fully inactivated. Second, phosphorylation of CYP2B1 in intact hepatocytes reduced by up to 75% toxification of CPA to mutagenic metabolites (totally dependent on the same preferentially CYP2B-catalyzed 4-hydroxylation of CPA as is the generation of highly cytotoxic species). Third, the phosphoacceptor-serine 128 of CYP2B1 in the consensus sequence for interaction with the protein kinase A represents an on/off switch for the activation of CPA depending on the phosphorylation conditions in the cell. Fourth, evidence is presented that the above-described events also occur in vivo. In conclusion, a successful therapy with CPA, helped by forced expression of CYP2B1 in tumor cells (as recently proposed) will, in addition, be profoundly modified by its phosphorylation status.

journal_name

Int J Cancer

authors

Oesch-Bartlomowicz B,Richter B,Becker R,Vogel S,Padma PR,Hengstler JG,Oesch F

doi

10.1002/ijc.1517

keywords:

subject

Has Abstract

pub_date

2001-12-01 00:00:00

pages

733-42

issue

5

eissn

0020-7136

issn

1097-0215

pii

10.1002/ijc.1517

journal_volume

94

pub_type

杂志文章
  • A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues.

    abstract::A new murine monoclonal antibody (MAb), E-9, has been raised using tissue-cultured human umbilical vein endothelial cells. The antigen recognized by this MAb is a peptide of 170 kDa under non-reducing conditions and 96 kDa under reducing conditions. MAb E-9 showed marked heterogeneity in its distribution in various ti...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910540303

    authors: Wang JM,Kumar S,Pye D,van Agthoven AJ,Krupinski J,Hunter RD

    更新日期:1993-05-28 00:00:00

  • Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir.

    abstract::Cytoskeleton and extracellular matrix-related proteins (CECMPs) represent the most common class of cancer mutants, owing to the large size of their coding regions and the randomness of mutagenesis. We used a bioinformatics approach to assess the impact of amino acid (AA) substitutions on the sensitivity of CECMPs to p...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.31111

    authors: Callahan BM,Patel JS,Fawcett TJ,Blanck G

    更新日期:2018-03-01 00:00:00

  • Efficient tumor targeting by single-domain antibody fragments of camels.

    abstract::The variable domain of functional heavy chain antibodies (VHH) devoid of light chains, found in camels, constitute the smallest intact antigen-binding domain fragment. Two camel single-domain fragments, cAb-Lys2 and cAb-Lys3, recognizing an overlapping epitope of lysozyme with a dissociation constant of 2 nM and 65 nM...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.10212

    authors: Cortez-Retamozo V,Lauwereys M,Hassanzadeh Gh G,Gobert M,Conrath K,Muyldermans S,De Baetselier P,Revets H

    更新日期:2002-03-20 00:00:00

  • In vivo growth inhibition of L1210 leukemia by 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A), a new inhibitor of S-adenosylmethionine decarboxylase.

    abstract::We studied the in vivo growth-inhibitory effect of the new S-adenosylmethionine decarboxylase inhibitor 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A). L1210-bearing DBA-2 mice were treated with increasing CGP 48664A doses from 1 day after i.p. L1210 cell inoculation. Treatment was continued for 4 days, after w...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910610212

    authors: Dorhout B,Te Velde RJ,Ferwerda H,Kingma AW,De Hoog E,Muskiet FA

    更新日期:1995-04-10 00:00:00

  • Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients.

    abstract::Chimeric bcr/abl fusion proteins are thought to be the molecular 'pathogen' of chronic myelogenous leukaemia (CML). Expression levels of the respective fusion RNAs reflect disease progression as well as remission upon therapeutic intervention in CML patients. However, there is no quick and reliable method that would a...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(20000601)86:5<741::aid-ijc

    authors: Kreuzer KA,Lass U,Nagel S,Ellerbrok H,Pauli G,Pawlaczyk-Peter B,Siegert W,Huhn D,Schmidt CA

    更新日期:2000-06-01 00:00:00

  • 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.

    abstract::The major obstacle for the treatment of gastric cancer is recurrence and metastasis; yet, its molecular mechanism is largely unknown. 2-methoxyestradiol (2-ME), a metabolite of the estradiol-17beta, has recently been demonstrated to have multifactorial effects against tumor proliferation and angiogenesis; how these ef...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.22963

    authors: Lin HL,Yang MH,Wu CW,Chen PM,Yang YP,Chu YR,Kao CL,Ku HH,Lo JF,Liou JP,Chi CW,Chiou SH

    更新日期:2007-12-01 00:00:00

  • Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions.

    abstract::Hormonal therapies targeting androgen receptor (AR) are effective in prostate cancer (PCa), but often the cancers progress to fatal castrate-resistant disease. Improved understanding of the cellular events during androgen deprivation would help to identify survival and stress pathways whose inhibition could synergize ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.29303

    authors: Saeed K,Östling P,Björkman M,Mirtti T,Alanen K,Vesterinen T,Sankila A,Lundin J,Lundin M,Rannikko A,Nordling S,Mpindi JP,Kohonen P,Iljin K,Kallioniemi O,Rantala JK

    更新日期:2015-06-01 00:00:00

  • Angiogenin promotes colorectal cancer metastasis via tiRNA production.

    abstract::Metastasis of colorectal cancer (CRC) is the leading cause of CRC-associated mortality. Angiogenin (ANG), a member of the ribonuclease A superfamily, not only activates endothelial cells to induce tumor angiogenesis, but also targets tumor cells to promote cell survival, proliferation and/or migration. However, its cl...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.32245

    authors: Li S,Shi X,Chen M,Xu N,Sun D,Bai R,Chen H,Ding K,Sheng J,Xu Z

    更新日期:2019-09-01 00:00:00

  • Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: Findings from the multicountry ABC-DO cohort study.

    abstract::Most breast cancer patients in sub-Saharan Africa are diagnosed at advanced stages after prolonged symptomatic periods. In the multicountry African Breast Cancer-Disparities in Outcomes cohort, we dissected the diagnostic journey to inform downstaging interventions. At hospital presentation for breast cancer, women re...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.33209

    authors: Foerster M,McKenzie F,Zietsman A,Galukande M,Anele A,Adisa C,Parham G,Pinder L,Schüz J,McCormack V,Dos-Santos-Silva I

    更新日期:2021-01-15 00:00:00

  • Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects.

    abstract::Tumor toxins are recombinant, bifunctional proteins which comprise a tumor-cell-specific recognition domain and an enzymatic toxin domain. We have evaluated the in vivo effects of a tumor toxin that specifically recognizes the erbB-3 and erbB-4 receptors (HRG beta 1-ETA). High doses of HRG beta 1-ETA administered syst...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19970317)70:6<682::aid-ijc

    authors: Groner B,Wick B,Jeschke M,Fiebig HH,Dengler W,Runau T,Mihatsch M,Kahl R,Schmidt M,Wels W,Stöcklin E

    更新日期:1997-03-17 00:00:00

  • The 5'-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer.

    abstract::The human surface antigen CD24 is over-expressed in small-cell lung cancer. Here we describe the isolation, sequencing and functional characterization of the 5'-flanking region of the human CD24 gene. A sequence (accession number: Y14692) of 3.4 kb regulates the activity of a luciferase reporter gene in CD24-expressin...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19981109)78:4<496::aid-ijc

    authors: Pass MK,Quintini G,Zarn JA,Zimmermann SM,Sigrist JA,Stahel RA

    更新日期:1998-11-09 00:00:00

  • Wnt2 as a new therapeutic target in malignant pleural mesothelioma.

    abstract::Malignant mesothelioma of the pleura (MPM) is a highly aggressive neoplasm with a poor prognosis and limited treatment options. A better understanding of its pathogenesis is essential to developing alternative therapeutic strategies. We previously demonstrated that the Wnt signaling pathway is activated in MPM through...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.21160

    authors: Mazieres J,You L,He B,Xu Z,Twogood S,Lee AY,Reguart N,Batra S,Mikami I,Jablons DM

    更新日期:2005-11-01 00:00:00

  • Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.

    abstract::Oxidative stress may be involved in carcinogenesis and biomarkers of oxidative stress like derivatives of reactive oxygen metabolites (d-ROM) may be useful for cancer prediction. However, no previous study assessed the association of pre-diagnostic d-ROM measurements with cancer incidence. We measured serum d-ROM leve...

    journal_title:International journal of cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/ijc.32073

    authors: Gào X,Wilsgaard T,Jansen EH,Holleczek B,Zhang Y,Xuan Y,Anusruti A,Brenner H,Schöttker B

    更新日期:2019-07-01 00:00:00

  • Implementation of the 7th edition AJCC staging system: Effects on staging and survival for pT1 melanoma. A Dutch population based study.

    abstract::In the 7th edition of the AJCC staging system, the mitotic rate criterion replaced Clark level to increase correct classification of high-risk thin melanoma patients (pT1B). Additionally, sentinel node biopsy (SNB) was recommended for nodal staging of pT1B melanomas. The aim of this article was to evaluate the effects...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.30607

    authors: Oude Ophuis CM,Louwman MW,Grünhagen DJ,Verhoef K,van Akkooi AC

    更新日期:2017-04-15 00:00:00

  • Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.

    abstract::Neuron-specific src mRNA, which is expressed in human brain tissue by alternative splicing, is associated with neural differentiation. Neuronal c-srcNI expression may be associated with the ability of neuroblastomas to mature; furthermore, c-srcN2 mRNA is induced in chemically differentiated neuroblastoma cells in vit...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910580607

    authors: Matsunaga T,Shirasawa H,Tanabe M,Ohnuma N,Kawamura K,Etoh T,Takahashi H,Simizu B

    更新日期:1994-09-15 00:00:00

  • Association between progression-free survival and patients' quality of life in cancer clinical trials.

    abstract::Quality of life outcomes provide essential information for patients and physicians in oncology care. However, the validity of progression-free survival (PFS) as a surrogate for quality of life, and the inclusion and reporting of quality of life endpoints in clinical trials, is unclear. We performed a retrospective stu...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.31957

    authors: Hwang TJ,Gyawali B

    更新日期:2019-04-01 00:00:00

  • Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.

    abstract::Pre-malignant and malignant human colorectal tumour epithelial cell lines both secreted precursor forms of the 2 cysteine proteinases, cathepsins B and L. The amount of proteinases secreted by these cell lines varied according to the cell density. Comparison at similar cell densities showed that the pre-malignant, ade...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910430323

    authors: Maciewicz RA,Wardale RJ,Etherington DJ,Paraskeva C

    更新日期:1989-03-15 00:00:00

  • RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53.

    abstract::A new non peptidic farnesyltransferase inhibitor, RPR-115135, in combination with 5-FU was studied in 10 human colon cancer cell lines (HCT-116, RKO, DLD-1, Colo-320, LoVo, SW-620, HT-29, HCT-15, Colo-205 and KM-12) carrying several mutations but well characterized for p53 and Ras status. We found that there was a sli...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.10461

    authors: Russo P,Malacarne D,Falugi C,Trombino S,O'Connor PM

    更新日期:2002-07-20 00:00:00

  • The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk.

    abstract::Many recent data indicate that some alleles encoded in the central major histocompatibility complex (MHC) region (Class III) of short arm of chromosome 6 may modify the risk of cancer development. Therefore we determined 4 single nucleotide polymorphisms (SNPs) of this region (TNF-alpha -308 G > A, RAGE -429 T > C, HS...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.22922

    authors: Tóth EK,Kocsis J,Madaras B,Bíró A,Pocsai Z,Fust G,Blaskó B,Karádi I,Adány R,Laki J

    更新日期:2007-10-15 00:00:00

  • Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.

    abstract::Marked variation in phenotypic expression among BRCA1 and BRCA2 mutation carriers may be partly explained by modifier genes that influence mutation penetrance. Variation in CAG/CAA repeat lengths coding for stretches of glutamines in the C-terminus of the AIB1 protein (amplified in breast cancer 1, a steroid receptor ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.21176

    authors: Hughes DJ,Ginolhac SM,Coupier I,Barjhoux L,Gaborieau V,Bressac-de-Paillerets B,Chompret A,Bignon YJ,Uhrhammer N,Lasset C,Giraud S,Sobol H,Hardouin A,Berthet P,Peyrat JP,Fournier J,Nogues C,Lidereau R,Muller D,Fricke

    更新日期:2005-11-01 00:00:00

  • galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.

    abstract::Galectin-1 and galectin-3 are galactoside-binding proteins involved in different steps of tumor progression and potential targets for therapy. We have investigated the expression of these galectins in 38 human bladder transitional-cell carcinomas of different histological grade and clinical stage and in 5 normal uroth...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19990219)84:1<39::aid-ijc8

    authors: Cindolo L,Benvenuto G,Salvatore P,Pero R,Salvatore G,Mirone V,Prezioso D,Altieri V,Bruni CB,Chiariotti L

    更新日期:1999-02-19 00:00:00

  • Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.

    abstract::The tumor-suppressor genes p14(ARF), p16(INK4a) and Tp53 are commonly inactivated in many tumors. We investigated their role in the pathogenesis of 9 bile tract cancer cell lines and 21 primary sporadic extrahepatic bile duct carcinomas. p53 and p16 protein expression was examined by Western blot analysis and immunohi...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.1639

    authors: Caca K,Feisthammel J,Klee K,Tannapfel A,Witzigmann H,Wittekind C,Mössner J,Berr F

    更新日期:2002-02-01 00:00:00

  • Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.

    abstract::APC10.1 is a new intestinal cell line derived from ApcMin/+ mice that retains both the heterozygous Apc genotype and a nonactivated Wnt signaling pathway and displays an early neoplastic phenotype. Although tumorigenic both in immunodepressed and in immunocompetent syngeneic mice, it requires a high cell dose and a lo...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.11690

    authors: De Giovanni C,Landuzzi L,Nicoletti G,Astolfi A,Croci S,Micaroni M,Nanni P,Lollini PL

    更新日期:2004-03-20 00:00:00

  • Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.

    abstract::The findings of mutations and the development of targeted therapies have improved lung cancer management. Still, the prognosis remains poor, and we need to know more about the genetic and epigenetic alterations in lung cancer. MicroRNAs are involved in crucial biological processes like carcinogenesis by regulating gen...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.28828

    authors: Bjaanaes MM,Halvorsen AR,Solberg S,Jørgensen L,Dragani TA,Galvan A,Colombo F,Anderlini M,Pastorino U,Kure E,Børresen-Dale AL,Brustugun OT,Helland A

    更新日期:2014-10-15 00:00:00

  • The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.

    abstract::The macrophage electrophoretic mobility (MEM) test was performed on guinea-pig macrophages treated with the interaction products of encephalitogenic protein and peripheral lymphocytes from 44 patients with colorectal cancer and 33 "healthy" controls. In 54/60 tests involving patients, statistically significant reducti...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910190407

    authors: Glaves D,Harlos JP,Weiss L

    更新日期:1977-04-15 00:00:00

  • Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.

    abstract::Comparisons of patients receiving different cancer treatments reflect the effects of both treatment and patient selection. In breast cancer, however, if radiotherapy decisions are unrelated to laterality, comparisons of left-sided and right-sided cancers can demonstrate the causal effects of higher-versus-lower cardia...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.32908

    authors: Henson KE,McGale P,Darby SC,Parkin M,Wang Y,Taylor CW

    更新日期:2020-09-01 00:00:00

  • Decrease of human pancreatic cancer cell tumorigenicity by alpha1,3galactosyltransferase gene transfer.

    abstract::The enzyme alpha1,3galactosyltransferase synthesizes the alphaGal epitope, a carbohydrate structure (Galalpha1,3Galbeta1,4GlcNAc-R), on glycoconjugates in lower mammals. The enzyme is absent in humans but large amounts of natural antibodies that recognize alphaGal epitopes are present in human serum. It is likely that...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.11470

    authors: Aubert M,Crotte C,Bernard JP,Lombardo D,Sadoulet MO,Mas E

    更新日期:2003-12-20 00:00:00

  • NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.

    abstract::Small cell lung cancers (SCLCs) and extrapulmonary small cell cancers (SCCs) are very aggressive tumors arising de novo as primary small cell cancer with characteristic genetic lesions in RB1 and TP53. Based on murine models, neuroendocrine stem cells of the terminal bronchioli have been postulated as the cellular ori...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.29835

    authors: Meder L,König K,Ozretić L,Schultheis AM,Ueckeroth F,Ade CP,Albus K,Boehm D,Rommerscheidt-Fuss U,Florin A,Buhl T,Hartmann W,Wolf J,Merkelbach-Bruse S,Eilers M,Perner S,Heukamp LC,Buettner R

    更新日期:2016-02-15 00:00:00

  • MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.

    abstract::MicroRNAs (miRNAs) play an important role in the regulation of a variety of cellular processes, including cell growth, differentiation, apoptosis and carcinogenesis. The purpose of this study was to elucidate the molecular mechanisms by which miR-148b acts as a tumor suppressor in colorectal cancer. The expression of ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.26485

    authors: Song Y,Xu Y,Wang Z,Chen Y,Yue Z,Gao P,Xing C,Xu H

    更新日期:2012-09-01 00:00:00

  • Mechanism of antitumor action of PKC activator, gnidimacrin.

    abstract::Daphnane-type diterpene gnidimacrin isolated from the Chinese plant Stellera chamaejasme L. is an antitumor agent that activates protein kinase C (PKC). The mechanism of antitumor action of gnidimacrin and the possible involvement of PKC were examined using sensitive K562 and refractory HLE cells. Gnidimacrin did bind...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19980717)77:2<243::aid-ijc

    authors: Yoshida M,Yokokura H,Hidaka H,Ikekawa T,Saijo N

    更新日期:1998-07-17 00:00:00